肠道菌群
代谢组学
生物
饮食性肥胖
肥胖
党参
内科学
内分泌学
生物化学
医学
生物信息学
胰岛素抵抗
中医药
替代医学
病理
作者
Ruibin Bai,Fang Cui,Wen Li,Yanping Wang,Zixia Wang,Yingrui Gao,Nan Wang,Qiaohong Xu,Fangdi Hu,Yan Zhang
出处
期刊:Food & Function
[Royal Society of Chemistry]
日期:2022-01-01
卷期号:13 (15): 8143-8157
被引量:28
摘要
in HFD mice. Based on serum non-targeted metabolomics analysis, 20 key metabolites responding to CPO treatment were identified, and their biological functions were mainly related to tryptophan and bile acid metabolism. The results demonstrate that CPO supplementation can ameliorate HFD-induced obesity and obesity-related metabolic disorders. It can be used as a novel gut microbiota modulator to prevent HFD-induced gut dysbiosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI